Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TACE(Transcatheter Arterial Chemoembolization)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT04954781
What this trial is testing

TACE Combined With Tislelizumab in Patients With Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Fudan University 25
Testing effectiveness (Phase 2)Study completedNCT04954794
What this trial is testing

TACE Combined with Sintilimab Plus Bevacizumab Biosimilar in Patients with Advanced Hepatocellular Carcinoma (TASK-02)

Who this might be right for
Hepatocellular Carcinoma
Fudan University 29
Testing effectiveness (Phase 2)Study completedNCT04297280
What this trial is testing

TACE Combined with Anti-PD-1 Antibody in Patients with Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University 25
Not applicableUnknownNCT05247996
What this trial is testing

TACE Combined With "Target Immune" Therapy for First-line Treatment in the Treatment of Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
The Central Hospital of Lishui City 98
Testing effectiveness (Phase 2)UnknownNCT00999843
What this trial is testing

Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Fudan University 30
Large-scale testing (Phase 3)Study completedNCT00494299
What this trial is testing

Phase III Study of BAY43-9006 in Patients With Advanced Hepatocellular Carcinoma (HCC) Treated After Transcatheter Arterial Chemoembolization (TACE)

Who this might be right for
Carcinoma, Hepatocellular
Bayer 458
Testing effectiveness (Phase 2)UnknownNCT04157140
What this trial is testing

Anlotinib In Combination With RFA And TACE in Patients With Middle-advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Jinglong Chen 48
Not applicableStudy completedNCT07075562
What this trial is testing

TACE Plus Bevacizumab for Hepatocellular Carcinoma With Portal Vein Invasion

Who this might be right for
Hepatocellular Carcinoma (HCC)
The First Hospital of Hebei Medical University 180
Not applicableLooking for participantsNCT07351669
What this trial is testing

Prospective Study on the Performance of Spectral CT for Evaluating Treatment Response After TACE in Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular CarcinomaTACE(Transcatheter Arterial Chemoembolization)CT
Zhongda Hospital 121
Not applicableLooking for participantsNCT06561399
What this trial is testing

Triple Therapy Sequential Radiotherapy in Unresectable HCC (TALENP003)

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Fujian Provincial Hospital 28
Testing effectiveness (Phase 2)UnknownNCT01217034
What this trial is testing

Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib

Who this might be right for
Hepatocellular CarcinomaUnresectable Hepatocellular CarcinomaCarcinoma, Hepatocellular+1 more
Kindai University 228
Large-scale testing (Phase 3)Looking for participantsNCT05738616
What this trial is testing

Lenvatinib Combined With TACE and Camrelizumab in Conversion Resection for Advanced Hepatocellular Carcinoma (LEN-TAC Study)

Who this might be right for
Advanced Hepatocellular Carcinoma
Wen Tianfu 196
Not applicableNot Yet RecruitingNCT06643533
What this trial is testing

Fecal Microbiota Transplantation in Reversing Drug Resistance in Unresectable HCC (TALENP004)

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Fujian Provincial Hospital 15
Testing effectiveness (Phase 2)Study completedNCT00826384
What this trial is testing

Transarterial Chemoembolization (TACE) Therapy of Hepatocellular Carcinoma (HCC) With Blocking Tumor Blood Temporarily and Enhancing Perfusion

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 352
Not applicableUnknownNCT03730675
What this trial is testing

Irradiation Stent Placement Plus TACE for HCC and PVTT

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombosis
Zhongda Hospital 308
Post-approval studies (Phase 4)UnknownNCT05416073
What this trial is testing

Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaTransarterial ChemoembolizationHepatic Arterial Infusion Chemotherapy+1 more
The Second Affiliated Hospital of Chongqing Medical University 70
Not applicableUnknownNCT01393197
What this trial is testing

Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas (TACE-KMG)

Who this might be right for
Carcinoma, Hepatocellular
Tianjin Medical University Cancer Institute and Hospital 2,480
Testing effectiveness (Phase 2)UnknownNCT02862587
What this trial is testing

Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

Who this might be right for
Precision CellsChemotherapyAdvanced Lung Cancer
Shanghai International Medical Center 40
Post-approval studies (Phase 4)UnknownNCT01102335
What this trial is testing

Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy

Who this might be right for
Hepatocellular Carcinoma
Fudan University 80
Not applicableStudy completedNCT00539253
What this trial is testing

Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI.

Who this might be right for
Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 45
Next Page